id: daidzein_treatment_to_neuropathy_symptoms
name: Daidzein Treatment (Soy Isoflavone) â†’ Diabetic Neuropathy Symptoms
from_node:
  node_id: daidzein_treatment
  node_name: Daidzein Treatment (Soy Isoflavone)
to_node:
  node_id: neuropathy_symptoms
  node_name: Diabetic Neuropathy Symptoms
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Daidzein reduces plasma glucose levels in diabetic animals'
- 'Step 2: Anti-hyperglycemic effect combined with NOX-4 inhibition reduces oxidative
  nerve damage'
- 'Step 3: Reduced oxidative stress improves nerve conduction velocity and sensory
  function'
- 'Step 4: Improvements manifest as reduced mechanical hyperalgesia, allodynia, and
  improved tail withdrawal and response latency'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: A. Laddha and Yogesh A. Kulkarni 2024. "Daidzein ameliorates peripheral
    neuropathy in Sprague Dawley rats." *Frontiers in Pharmacology*. https://doi.org/10.3389/fphar.2024.1385419
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.267423'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: baseline_neuropathy_severity
  direction: weakens
  strength: moderate
  description: Treatment initiated 6 weeks after diabetes induction, suggesting timing
    of intervention affects efficacy
